Aminate Base

Aminate Base Uses, Dosage, Side Effects, Food Interaction and all others data.

Aminate Base has been developed by Synvista Therapeutics, Inc for the treatment of diabetic kidney disease. It is an advanced glycation end product inhibitor which manages diabetic nephropathy, either alone or in combination with other therapies. It is beneficial in treating patients with diabetic nephropathy.

Trade Name Aminate Base
Generic Pimagedine
Pimagedine Other Names Aminate base, Aminoguanidine, Guanyl hydrazine, Hydrazinecarboximidamide, Monoaminoguanidine, Pimagedine
Type
Formula CH6N4
Weight Average: 74.0851
Monoisotopic: 74.059246212
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Aminate Base
Aminate Base

Uses

Investigated for use/treatment in diabetic kidney disease.

How Aminate Base works

Aminate Base reportedly inhibits the formation of glycosylated proteins (advanced glycosylation end-products) and has other actions including inhibition of aldose reductase.

Innovators Monograph

You find simplified version here Aminate Base

*** Taking medicines without doctor's advice can cause long-term problems.
Share